Odontogenic myxoma (OM) is a rare benign tumor originating from the odontogenic mesenchyme, characterized by locally aggressive behavior in the jaw bones. We present a case report of a 36-year-old ...
Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.
For organs to develop, grow and regenerate, cells must proliferate. But when that process goes awry, leading to uncontrolled cell growth, cancer can emerge.
Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...
Heather and Hiro Frost spent so much time at the ProMedica Russell J. Ebeid Children’s Hospital, Heather decided she wanted to give back as much as she could. So, she got a job there.
UToledo Health has a new tool in its arsenal to aid in the fight against cancer. The new technology helps doctors remove ...
NIH-supported researchers have developed a new method using a protein from tardigrades to help protect healthy tissue during ...
We recently published a list of Top 10 Penny Stocks That Will Skyrocket. In this article, we are going to take a look at ...
While Annika Meier battles medulloblastoma, she and her parents are also raising money to help other pediatric cancer ...
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
Teddi Mellencamp's dad has reportedly not stopped showing up for his daughter since she started the journey towards beating ...
BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results